Prestige Consumer Healthcare Inc.
PBH · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $4 | $4 | $3 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $2 |
| Enterprise Value | $5 | $5 | $4 | $4 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 1.1% | -0.2% | 3.8% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 55.8% | 55.5% | 55.4% | 57.1% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 31.8% | 33.2% | 0.7% | 33% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 18.9% | 18.6% | -7.3% | 18.9% |
| EPS Diluted | 4.29 | 4.17 | -1.65 | 4.04 |
| % Growth | 2.9% | 352.7% | -140.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |